Mutation of growth hormone receptor gene in men found to lengthen lifespan

June 19, 2017 by Bob Yirka report
Credit: CC0 Public Domain

(Medical Xpress)—A team of researchers with member affiliations in the U.S., France and Israel has found that a mutation in a growth hormone receptor gene can make some men live longer. In their paper published on the open access site Science Advances, the group outlines their study of several different groups of men and the differences they found for those with the growth hormone receptor exon 3 deletion.

Growth hormones are molecules that connect to other molecules that reside on the surface of a cell—these growth receptors then trigger signals telling the cell to speed up its growth or in some cases to release molecules known as growth factors. Prior research has shown that for some people, there is a genetic mutation that prevents the development of certain hormone receptors. Such people still have , but they are shaped differently. In this new effort, the researchers looked at mutation deletions in exon 3 and found that males who express it tend to live on average a decade longer, and also grow on average an inch taller.

The team first looked at a group (567 people) of Ashkenazi Jews over age 60 and at their children. They found that the mutation was present in 12 percent of men tested over the age of 100—a number that was three times higher than for men 70 years old. Men with the mutation lived on average 10 years longer than those without it. They found no difference for women. The team then tested other groups, such as those participating in the Cardiovascular Health Study, the Old Order Amish and the French Long-Lived Study.

The video will load shortly
Scientists report that the prevalence of variations in a growth hormone receptor gene increased with age in four groups of long-lived individuals. Males with the variations were taller and lived approximately 10 years long. The researchers concluded that the growth receptor variant positively affects male longevity. Credit: Gil Atzmon

The researchers report finding nearly identical results among all the groups. They suggest this indicates that exon 3 is clearly involved in longevity, though they readily acknowledge that it is almost certainly one of many agents involved in the overall process. But, they also note that their results suggest that further study should be conducted with larger groups to confirm their results. If others find the same thing, further research could explore the impact of mimicking the mutation to see whether it might be possible to extend the lifespan for males and perhaps to make them a little taller if they so choose.

Explore further: Growth-stunting gene may spare South Americans from dementia

More information: The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature, Science Advances  16 Jun 2017: Vol. 3, no. 6, e1602025, DOI: 10.1126/sciadv.1602025 , http://advances.sciencemag.org/content/3/6/e1602025

Abstract
Although both growth hormone (GH) and insulin-like growth factor 1 (IGF-1) signaling were shown to regulate life span in lower organisms, the role of GH signaling in human longevity remains unclear. Because a GH receptor exon 3 deletion (d3-GHR) appears to modulate GH sensitivity in humans, we hypothesized that this polymorphism could play a role in human longevity. We report a linear increased prevalence of d3-GHR homozygosity with age in four independent cohorts of long-lived individuals: 841 participants [567 of the Longevity Genes Project (LGP) (8% increase; P = 0.01), 152 of the Old Order Amish (16% increase; P = 0.02), 61 of the Cardiovascular Health Study (14.2% increase; P = 0.14), and 61 of the French Long-Lived Study (23.5% increase; P = 0.02)]. In addition, mega analysis of males in all cohorts resulted in a significant positive trend with age (26% increase; P = 0.007), suggesting sexual dimorphism for GH action in longevity. Further, on average, LGP d3/d3 homozygotes were 1 inch taller than the wild-type (WT) allele carriers (P = 0.05) and also showed lower serum IGF-1 levels (P = 0.003). Multivariate regression analysis indicated that the presence of d3/d3 genotype adds approximately 10 years to life span. The LGP d3/d3-GHR transformed lymphocytes exhibited superior growth and extracellular signal–regulated kinase activation, to GH treatment relative to WT GHR lymphocytes (P < 0.01), indicating a GH dose response. The d3-GHR variant is a common genetic polymorphism that modulates GH responsiveness throughout the life span and positively affects male longevity.

Related Stories

New approaches to cell study contributes to cancer research

September 12, 2014

At Ryerson, some of our top researchers are committed to finding out how cells function, and to building our knowledge of the basic science of cellular function while investigating diseases and the potential for new therapies ...

Recommended for you

Lab grown human colons change study of GI disease

June 22, 2017

Scientists used human pluripotent stem cells to generate human embryonic colons in a laboratory that function much like natural human tissues when transplanted into mice, according to research published June 22 in Cell Stem ...

Paracetamol during pregnancy can inhibit masculinity

June 22, 2017

Paracetamol is popular for relieving pain. But if you are pregnant, you should think twice before popping these pills according to the researchers in a new study. In an animal model, Paracetamol, which is the pain-relieving ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Osiris1
not rated yet Jun 19, 2017
Next step after discovery like this.......application!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.